Skip to content

Efficacy of esketamine in patients undergoing painless endoscopy

Efficacy of esketamine in patients undergoing painless endoscopy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400086415
Enrollment
Unknown
Registered
2024-07-01
Start date
2024-07-02
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Group Propofol (Group C):Intravenous injection of propofol in anesthesia induction
Group Esketamine (Group E):Intravenous injection of propofol combined with esketamine in anesthesia induction
Group Sufentanil (Group S):Intravenous injection of propofol combined with sufentanil in anesthesia induction

Sponsors

Sir Run Run Hospital Affiliated to Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: (1) Patients receiving total intravenous anesthesia; (2) Patients with complete clinical records; (3) ASA classification I-III

Exclusion criteria

Exclusion criteria: (1) Patients with a history of allergy to the experimental drug; (2) Patients with heart, lung, liver, kidney, blood and other important system diseases; (3) Patients with communication or cognitive impairment; (4) Patients with symptoms of respiratory infection

Design outcomes

Primary

MeasureTime frame
Blood Pressure (BP);Heart Rate (HR);Oxygen Saturation (SpO2);

Secondary

MeasureTime frame
Consumption of anesthetics;The number of jaw braces;Anesthesia recovery time;Respiratory depression;

Countries

China

Contacts

Public ContactYin Ning

Sir Run Run Hospital Affiliated to Nanjing Medical University

yinning882000@126.com+86 152 5175 7835

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026